Abstract
We have shown previously that neutrophils (PMNs) from patients with asthma have a more potent stimulated respiratory burst than normals and that their respiratory burst is significantly less suppressed with exposure to 2-chloroadenosine (2-CADO). The present studies investigated the basis of this defect in responsiveness to 2-CADO. PMNs obtained from asthmatics either not on theophylline (minus theophylline) or taking theophylline (plus theophylline) generated significantly more superoxide in response to 2×10−8 M FMLP (2.08±0.36 nmol/5×105 PMNs (minus theophylline) (P<0.01 compared to controls) vs. 2.16±0.44 (plus theophylline) (P<0.01) as compared to controls (1.05±0.17 nmol). In the presence of FMLP (2×10−8 M), PMNs from the minus theophylline cohort had less 2-CADO (10−6 M) -mediated suppression of superoxide generation as compared to controls (38.3±3.8% vs. 67±3.8%; (P<0.001). The plus theophylline group exhibited suppression values similar to controls (64.5±7.2%). Theophylline, in the presence of a physiological concentration of 2-CADO (0.1μM) accentuated the suppression of the respiratory burnt in normals (74.1±5.9%, 80.1±4.9% (P<0.02) and 84.7±3.8% (P<0.02) at 0, 10, and 100μM, respectively). PMNs from asthmatics not taking theophylline demonstrated suppression values of 46.2±6%, 53.8±6.6% (P=NS), and 63.2±7.1% (P<0.01), respectively. Resting PMNs from normal controls generated 0.97±0.20 pmol cAMP/107 cells compared to 2.83±0.75 pmol in the pressnce of 0.1μM 2-CADO. The combination of 2-CADO and theophylline (10–100μM) produced cAMP concentrations not significantly different from that observed with 2-CADO alone. These findings support the existence of a novel cAMP-independent adenosine receptor in PMNs. The specific binding of 10−8 M3H-labeled 2-CADO (in Δ cpm) was 10,358 ± 1502 (P < 0.001 compared to controls), 5468 ± 843 (NS compared to controls), and 3751 ± 477 in the plus theophylline group, minus theophylline group, and controls, respectively. Such up-regulation of specific binding may represent the effects of theophylline as shown by the specific binding of [3H]2-CADO in PMNs from normal controls exposed to 10 μM theophylline for 30 min (6013 ± 969) compared to unexposed PMNs (3768 ± 656; P < 0.05). These data support an antiinflammatory mechanism of action for theophylline in the therapy of asthma and suggest that this may occur through potentiation of the antiinflammatory mediator adenosine.
Similar content being viewed by others
References
O'byrne, P. M., E. H. Walters, B. D. Gold, H. A. Aizawa, L. M. Fabbri, S. E. Alpert, J. A. Nade, andM. J. Holtzman. 1984. Neutrophil depletion inhibits airway hyperrespon-siveness induced by ozone exposure.Am. Rev. Respir. Dis. 130:214–219.
Metzger, W. J., D. Zavala, H. B. Richerson, P. Moseley, P. Iwamota, M. Monick, K. Sojoerosma, andG. W. Hunninghake. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs.Am. Rev. Respir. Dis. 135:433–440.
Demonchy, J. G. R., H. F. Kauffman, P. Venge, et al. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthma reactions.Am. Rev. Respir. Dis. 131:373–376.
Gin, W., andA. B. Kay. 1985. The effect of corticosteroids on monocyte and neutrophil activation in bronchial astima.J. Allergy Clin. Immunol. 76:675–682.
Gin, W., R. J. Shaw, andA. B. Kay. 1985. Airways reversibility after prednisolone therapy in chronic asthma is associated with alterations in leukocyte function.Am. Rev. Respir. Dis. 132:1199–1203.
Arm, J. P., J. J. Walpoft, andT. H. Lee. 1989. Expression of complement receptors type l (CR1) and type 3 (CR3l on circulating granulocytes in experimentally provoked asthma.J. Allergy Clin. Immunol. 83:649–655.
Wang, S. R., C. M. Yang, S. S. M. Wang, S. H. Han, andB. N. Chiang. 1986. Enhancement of A23187-induced production of the slow-reacting substance on peripheral leukocytes from subjects with asthma.J. Allergy Clin. Immunol. 77:465–471.
Mita, H., Y. Yui, N. Taniguchi, H. Yasueda, andT. Shida. 1985. Increased activity of 5-lipoxygenase in polymorphonuclear leukocytes from asthmatic patients.Life Sci. 37:907–914.
Sustiel, A. M., B. Z. Joseph, R. E. Rocklin, andL. Borish. 1989. Asthmatic patients have primed neutrophils that exhibit diminished responsiveness to adenosine.Am. Rev. Respir. Dis. 140:1556–1561.
Klempner, M. S., C. A. Dinarello, W. R. Henderson, andJ. I. Gallin. 1979. Stimulation of neutrophil oxygen-dependent metabolism by human leukocyte pyrogen.J. Clin. Invest. 64:996–1002.
Pick, E., andD. Mizell. 1981. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic immunoassay reader.J. Immunol. Methods 46:211–216.
Styrt, B., R. E. Rocklin, andM. S. Klempner. 1988. Characterization of the neutrophil respiratory burst in atopy.J. Allergy Clin. Immunol. 81:20–26.
Neijens, H. J., R. E. Raatgeep, J. Degenhart, E. J. Duiverman, andK. F. Kerrebijn. 1984. Altered leukocyte response in relation to the basic abnormality in children with asthma and bronchial hyperresponsiveness.Am. Rev. Respir. Dis. 130:744–747.
Postma, D. S., T. E. Remkema, J. A. Noordhoek, H. Faber, H. J. Sluiter, andH. Kauff-Man. 1988. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction.Am. Rev. Respir. Dis. 137:57–61.
Fletcher, M. P., andJ. I. Gallin. 1983. Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine.Blood 62:792–799.
Lew, P. D. 1990. Receptors and intracellular signaling in human neutrophils.Am. Rev. Respir. Dis. 141:S127-S131.
Rossi, P., P. Dri, G. Berton, andP. Bellavite. 1981. Activation of oxygen metabolism in polymorphonuclear leucocytes: Activity of soluble and membrane bound NADPH and NADH oxidases.Bull. Eur. Physiopathol. Respir. 17S:167–174.
Berton, G., L. Zeni, M. A. Cassatella, andF. Rossi. 1986. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils.Biochem. Biophys. Res. Commun. 138:1276–1282.
Cronstein, B. N., E. D. Rosenstein, S. B. Kramer, G. Weissmann, andR. Hirschhorn. 1985. Adenosine: A physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.J. Immunol. 135:1366–1371.
Hutchison, K. A., B. Nevins, F. Perini, andI. H. Fox. 1990. Soluble and membrane associated human low affinity adenosine binding protein (adenotin): Properties and homology with mammalian and avian stress proteins.Biochemistry 29:5138–5144.
Klotz, I. M. 1982. Numbers of receptor sites from Scatchard graphs: Facts and fantasies.Science 217:1247–1249.
Ramkumar, V., J. R. Bumgarner, K. A. Jacobson, andG. L. Stiles. 1988. Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion.J. Clin. Invest. 82:242–247.
Collado-Escobar, D., J. R. Cunha-Melo, andM. A. Beaven. 1990. Treatment with dexamethasone downregulates IgE-receptor-mediated signals and upregulates adenosine-receptor-mediated signals in a rat mast cell (RBL-2H3) line.J. Immunol. 144:244–250.
Holgate, S. T., J. S. Mann, andM. J. Cushley. 1984. Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthines.J. Allergy Clin. Immunol. 74:302–306.
Fredholm, B. B. 1985. On the mechanism of action of theophylline and caffeine.Acta Med. Scand. 217:149–153.
Pauwels, R., D. Van Rentergheyem, M. Van Der Straeten, N. Johannessen, andC. G. A. Persson. 1985. The effect of theophylline and enprofylline on allergen induced bronchoconstriction.J. Allergy Clin. Immunol. 76:583–590.
Mapp, C., P. Boschetto, L. Dal Vecchio, S. Crescioli, N. de Marzo, D. Paleari, andL. M. Fabbri. 1987. Protective effect of anti-asthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocynate in sensitized subjects.Am. Rev. Respir. Dis. 136:1403–1407.
Andersson, P., C. Brange, B. Sonmark, G. Stahre, I. Erjefalt, E. Wieslander, andC. G. A. Persson. 1985. Anti-anaphylactic and anti-inflammatory effects of xanthines in the lung.In Anti-asthma Xanthines and Adenosine. K. E. Andersson, and C. G. A. Persson, editors. Excerpta Medica, Amsterdam. 187–192.
Cockroft, D. W. 1990. Airway hyperresponsiveness in asthma.Hosp. Pract. 25:111–129.
Cockroft, D. W., K. Y. Murdock, B. P. Gore, P. M. O'byrne, andP. Manning. 1989. Theophylline does not inhibit allergen induced increase in airway responsiveness to methacholine.J. Allergy Clin. Immunol. 83:913–920.
Dutoit, J. I., C. M. Salome, andA. J. Woolcock. 1987. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.Am. Rev. Respir. Dis. 136:1174–1178.
Nielson, C. P., J. J. Crowley, B. J. Cusack, andR. E. Vestal. 1986. Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation.J. Allergy Clin. Immunol. 78:660–667.
Schmeichel, C. J., andL. L. Thomas. 1987. Methylxanthine bronchodilators potentiate multiple human neutrophil functions.J. Immunol. 138:1896–1903.
Yukawa, T., C. Krogel, P. Chanez, G. Dent, D. Ukena, K. Chung, andP. J. Barnes. 1989. Effect of theophylline and adenosine on eosinophil function.Am. Rev. Respir. Dis. 140:327–333.
Cox, J. P., andM. L. Karnovsky. 1973. The depression of phagocytosis by the exogenous cyclic nucleotides, prostaglandins and theophylline.J. Cell Biot. 59:480–490.
McGarrity, S. T., A. H. Stephenson, andR. O. Webster. 1989. Regulation of human neutrophil functions by adenine nucleotides.J. Immunol,142:1986–1994.
Cronstein, B. N., S. B. Kramer, G. Weissmann, andR. Hirschhorn. 1983. Adenosine: A physiological modulator of superoxide anion generation by human neutrophils.J. Exp. Med. 158:1160–1177.
Hirschhorn, R., V. Roegner-Manasclo, L. Kuritsky, andF. Rosen. 1981. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase deficient patients.J. Clin. Invest. 68:1387–1393.
Fredholm, B. B. 1981. Release of adenosine from rat lung by antigen and compound 48/80.Acta Physiol. Scand. 111:507–508.
Mentzer, R. M., R. Rubo, andR. M. Berne. 1975. Release of adenosine in hypoxic canine lung tissue and its possible role in pulmonary circulation.Am. J. Physiol. 229:1625–1631.
Cronstein, B., L. Daguma, D. Nichols, A. J. Hutchison, andM. Williams. 1990. The adenosine/neutrophil paradox resolved: Human neutrophils possess both A2, and A2 receptors that promote chemotaxis und inhibit O−2 generation, respectively.J. Clin. Invest. 85:1150–1157.
Van Calker, D., M. Muller, andB. Hamprecht. 1978. Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells.Nature 276:839.
Van Calker, D., M. Muller, andB. Hamprecht. 1979. Adenosine regulates via two types of receptors, the accumulation of cyclic AMP in cultured brain cells.J. Neurochem. 33:999.
Londos, C., M. F. D. Cooper, andJ. Wolff. 1980. Subclasses of external adenosine receptors.Proc. Natl. Acad. Sci. U.S.A. 77:2551.
Stiles, G. L. 1990. Adenosine receptors and beyond: Molecular mechanisms of physiological regulation.Clin. Res. 38:10–18.
Fredholm, B. B., andC. G. A. Persson. 1982. Adenosine induced bronchoconstriction in asthma; specificity, and relationship to airway reactivity.Eur. J. Pharmacol. 81:673.
Bruns, R. F., J. W. Daly, andS. H. Snyder. 1983. Adenosine receptor binding structure-activity analysis generates extremely potent xanthine antagonists.Proc. Natl. Acad. Sci. U.S.A. 80:2077.
Cronstein, B. N., S. B. Kramer, E. D. Rosenstein, H. M. Korchak, G. Weismann, andR. Hirschhorn. 1988. Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization.Biochem. J. 252:709–715.
Kolbeck, R. C., W. A. Speir, G. O. Carrier, andE. D. Bransome, Jr. 1979. Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline.Lung 156:173-l83.
Higbee, M. D., M. Kumaf, andS. P. Galant. 1982. Stimulation of endogenous catecholamine release by theophylline: A proposed additional mechanism of action of theophylline effects.J. Allergy Clin. Immunol. 70:377–382.
Riberio, J. A., andA. M. Sebastiao. 1986. Adenosine receptors and calcium: Basis for proposing a third (A3) adenosine receptor.Prog. Neurobiol. 26:179–209.
Roberts, A., A. C. Newby, M. B. Hallett, andA. K. Campbell. 1985. Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leukocytes.Biochem. J. 227:669–674.
Pasini, L. F., P. L. Capecchi, A. Orrico, L. Ceccatelli, andT. Perri. 1985. Adenosine inhibits polymorphonuclear leukocyte in vitro activation: A possible role as an endogenous calcium entry blocker.J. Immunopharmacol. 7:203–215.
Balazovich, K. J., andL. A. Boxer. 1990. Extracellular adenosine nucleotides stimulate protein kinase C activity and human neutrophil activation.J. Immunol. 144:631–637.
Sullivan, G. W., J. Linden, E. L. Hewlett, H. T. Carper, J. B. Hylton, andG. L. Mandell. 1990. Adenosine and related compounds counteract tumor necrosis factor a inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.J, Immunol. 145:1537–1544.
Author information
Authors and Affiliations
Additional information
This research was supported by NIH grants AI24843 and AI24848.
Rights and permissions
About this article
Cite this article
Joseph, B.Z., Sustiel, A.M. & Borish, L. Neutrophils from asthmatics exhibit diminished responsiveness to 2-chloroadenosine which is reversed by theophylline. Inflammation 16, 101–116 (1992). https://doi.org/10.1007/BF00918951
Issue Date:
DOI: https://doi.org/10.1007/BF00918951